Report cover image

Global Treatment for Mental Health Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 197 Pages
SKU # APRC20360733

Description

Summary

According to APO Research, the global Treatment for Mental Health market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Treatment for Mental Health is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Treatment for Mental Health is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Treatment for Mental Health market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Treatment for Mental Health is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Treatment for Mental Health market include Takeda, Johnson & Johnson, Eli Lilly, Pfizer and Shionogi, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Treatment for Mental Health, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Treatment for Mental Health, also provides the value of main regions and countries. Of the upcoming market potential for Treatment for Mental Health, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Treatment for Mental Health revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Treatment for Mental Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Treatment for Mental Health company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Treatment for Mental Health Segment by Company

Takeda
Johnson & Johnson
Eli Lilly
Pfizer
Shionogi
Treatment for Mental Health Segment by Type

Teenager
Adult
Treatment for Mental Health Segment by Application

Hospital
Clinic
Others
Treatment for Mental Health Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Treatment for Mental Health status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Treatment for Mental Health key companies, revenue, market share, and recent developments.
3. To split the Treatment for Mental Health breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Treatment for Mental Health market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Treatment for Mental Health significant trends, drivers, influence factors in global and regions.
6. To analyze Treatment for Mental Health competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment for Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Treatment for Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment for Mental Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Treatment for Mental Health industry.
Chapter 3: Detailed analysis of Treatment for Mental Health company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Treatment for Mental Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Treatment for Mental Health in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Treatment for Mental Health Market Size, 2020 VS 2024 VS 2031
1.3 Global Treatment for Mental Health Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Treatment for Mental Health Market Dynamics
2.1 Treatment for Mental Health Industry Trends
2.2 Treatment for Mental Health Industry Drivers
2.3 Treatment for Mental Health Industry Opportunities and Challenges
2.4 Treatment for Mental Health Industry Restraints
3 Treatment for Mental Health Market by Company
3.1 Global Treatment for Mental Health Company Revenue Ranking in 2024
3.2 Global Treatment for Mental Health Revenue by Company (2020-2025)
3.3 Global Treatment for Mental Health Company Ranking (2023-2025)
3.4 Global Treatment for Mental Health Company Manufacturing Base and Headquarters
3.5 Global Treatment for Mental Health Company Product Type and Application
3.6 Global Treatment for Mental Health Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Treatment for Mental Health Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Treatment for Mental Health Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Treatment for Mental Health Market by Type
4.1 Treatment for Mental Health Type Introduction
4.1.1 Teenager
4.1.2 Adult
4.2 Global Treatment for Mental Health Sales Value by Type
4.2.1 Global Treatment for Mental Health Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Treatment for Mental Health Sales Value by Type (2020-2031)
4.2.3 Global Treatment for Mental Health Sales Value Share by Type (2020-2031)
5 Treatment for Mental Health Market by Application
5.1 Treatment for Mental Health Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Others
5.2 Global Treatment for Mental Health Sales Value by Application
5.2.1 Global Treatment for Mental Health Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Treatment for Mental Health Sales Value by Application (2020-2031)
5.2.3 Global Treatment for Mental Health Sales Value Share by Application (2020-2031)
6 Treatment for Mental Health Regional Value Analysis
6.1 Global Treatment for Mental Health Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Treatment for Mental Health Sales Value by Region (2020-2031)
6.2.1 Global Treatment for Mental Health Sales Value by Region: 2020-2025
6.2.2 Global Treatment for Mental Health Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Treatment for Mental Health Sales Value (2020-2031)
6.3.2 North America Treatment for Mental Health Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Treatment for Mental Health Sales Value (2020-2031)
6.4.2 Europe Treatment for Mental Health Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Treatment for Mental Health Sales Value (2020-2031)
6.5.2 Asia-Pacific Treatment for Mental Health Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Treatment for Mental Health Sales Value (2020-2031)
6.6.2 South America Treatment for Mental Health Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Treatment for Mental Health Sales Value (2020-2031)
6.7.2 Middle East & Africa Treatment for Mental Health Sales Value Share by Country, 2024 VS 2031
7 Treatment for Mental Health Country-level Value Analysis
7.1 Global Treatment for Mental Health Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Treatment for Mental Health Sales Value by Country (2020-2031)
7.2.1 Global Treatment for Mental Health Sales Value by Country (2020-2025)
7.2.2 Global Treatment for Mental Health Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.3.2 USA Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.4.2 Canada Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.6.2 Germany Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.7.2 France Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.7.3 France Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.9.2 Italy Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.10.2 Spain Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.11.2 Russia Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.14.2 China Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.14.3 China Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.15.2 Japan Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.17.2 India Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.17.3 India Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.18.2 Australia Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.22.2 Chile Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.24.2 Peru Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.26.2 Israel Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.27.2 UAE Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.29.2 Iran Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Treatment for Mental Health Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Treatment for Mental Health Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Treatment for Mental Health Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Takeda
8.1.1 Takeda Comapny Information
8.1.2 Takeda Business Overview
8.1.3 Takeda Treatment for Mental Health Revenue and Gross Margin (2020-2025)
8.1.4 Takeda Treatment for Mental Health Product Portfolio
8.1.5 Takeda Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Treatment for Mental Health Revenue and Gross Margin (2020-2025)
8.2.4 Johnson & Johnson Treatment for Mental Health Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Eli Lilly
8.3.1 Eli Lilly Comapny Information
8.3.2 Eli Lilly Business Overview
8.3.3 Eli Lilly Treatment for Mental Health Revenue and Gross Margin (2020-2025)
8.3.4 Eli Lilly Treatment for Mental Health Product Portfolio
8.3.5 Eli Lilly Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Treatment for Mental Health Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Treatment for Mental Health Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Shionogi
8.5.1 Shionogi Comapny Information
8.5.2 Shionogi Business Overview
8.5.3 Shionogi Treatment for Mental Health Revenue and Gross Margin (2020-2025)
8.5.4 Shionogi Treatment for Mental Health Product Portfolio
8.5.5 Shionogi Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.